Literature DB >> 28019126

Mode of delivery among women admitted with polyhydramnios.

Abeer Suleiman1, Raed Salim1,2.   

Abstract

A retrospective matched case control study was conducted to examine the incidence of caesarean delivery (CD) among women admitted with polyhydramnios with and without a trial of labour compared to women with normal amniotic fluid index (AFI). Singleton pregnancies diagnosed with polyhydramnios upon admission to labour between 2003 and 2013 were included. A control group (normal AFI) matched at a ratio of 1:1 was randomly selected. Primary outcome was the incidence of CD. A total of 588 women were included. The overall incidence of CD was significantly higher among women with polyhydramnios (31.3%) compared to the controls (18.7%), (p < .001). The incidences of both non-labouring caesarean and intrapartum operative deliveries were significantly higher among women with polyhydramnios compared to the controls (p = .007 and p = .01, respectively). On a multiple logistic regression model, polyhydramnios was found to be an independent risk factor for delivery by a caesarean (p = .0015; OR 2.0; 95%CI 1.30-2.90).

Entities:  

Keywords:  Labouring caesarean; macrosomia; non-labouring caesarean; operative delivery; polyhydramnios

Mesh:

Year:  2016        PMID: 28019126     DOI: 10.1080/01443615.2016.1253669

Source DB:  PubMed          Journal:  J Obstet Gynaecol        ISSN: 0144-3615            Impact factor:   1.246


  2 in total

1.  Multicentre study of maternal and neonatal outcomes in individuals with Prader-Willi syndrome.

Authors:  Preeti Singh; Ranim Mahmoud; June-Anne Gold; Jennifer L Miller; Elizabeth Roof; Roy Tamura; Elisabeth Dykens; Merlin G Butler; Dan J Driscoll; Virginia Kimonis
Journal:  J Med Genet       Date:  2018-05-18       Impact factor: 6.318

2.  Understanding Factors Leading to Primary Cesarean Section and Vaginal Birth After Cesarean Delivery in the Friuli-Venezia Giulia Region (North-Eastern Italy), 2005-2015.

Authors:  L Cegolon; G Mastrangelo; G Maso; G Dal Pozzo; L Ronfani; A Cegolon; W C Heymann; F Barbone
Journal:  Sci Rep       Date:  2020-01-15       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.